The Cellca Story: Evolution Of A Cell Line Development Technology
Source: Sartorius
Sartorius' in-house cell line development (CLD) service began as a small start-up, Cellca GmbH, in 2005 and has improved over many years to become one of the leading technologies on the market. Sartorius research fellow, Christoph Zehe, joined Cellca in 2007, and that is where he established a leading platform technology for the generation of high-expressing cell lines. Here, he walks us through the evolution of this CLD technology.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
Sartorius
This website uses cookies to ensure you get the best experience on our website. Learn more